Key Highlights

  • This article reviews a peer reviewed study on pregnenolone, hormone levels, and scoliosis progression. For pregnenolone supplements, the recommended dosage can vary depending on individual needs and goals, but typical doses range from 5 mg to 50 mg daily. It is important to consult a healthcare provider before starting any supplement to determine the appropriate amount for your body and to monitor hormone levels.
  • Pregnenolone is one of the steroid hormones your body makes and uses to build other hormones.
  • The study looked at a scoliosis cohort and a ScoliSMART care model, not standard clinical trials. There are different forms of pregnenolone supplements available, including tablets, capsules, topical creams, and sublingual formulations, which may be used to address varying needs concerning pregnenolone levels.
  • Results suggest a link between pregnenolone levels and progression risk, but not proof of cause.
  • Pregnenolone supplements can have side effects, so medical guidance matters.
  • The paper may inform Scoliosis treatment choices, alongside a scoliosis brace, Scoliosis exercises, or Scoliosis surgery.

If you are tracking scoliosis, you may wonder whether hormones play a role. That is where pregnenolone enters the picture. Pregnenolone is one of the steroid hormones made in your body, and a new study explored how it may relate to scoliosis progression. This matters because families often want more than watchful waiting. They want useful clues. In this article, you will get a clear summary of what the study asked, what it found, and what it still does not prove.

What the Latest Study Reveals About Pregnenolone and Scoliosis Progression

Understanding Pregnenolone and Its Role in the Body

Pregnenolone is a natural chemical made mainly by your adrenal glands. Your body uses it in the synthesis of other hormones, which is why people often call it a pro-hormone. It helps your body make different steroid hormones, and there are common reasons for its use, such as progesterone, estrogen, testosterone, glucocorticoids, and mineralocorticoids.

It is also classed as one of the neuroactive steroids. That means it may affect brain function, brain health, cognitive function, and even conditions like hair loss through the central nervous system. Some people use it for mental health, memory, or mood, but the benefits of pregnenolone supplements are still not well defined.

Pregnenolone is a steroid hormone your body makes naturally. It is produced by the adrenal glands and then used to build many other important chemicals. These include progesterone, estrogen, testosterone, and other hormones that affect stress response, reproductive health, and many body systems. People who may consider taking pregnenolone include those who have been diagnosed with low levels of pregnenolone or related hormones, often after consulting with a healthcare provider. However, individuals who are pregnant, breastfeeding, have hormone-sensitive conditions, or are taking medications that affect hormone balance should avoid pregnenolone unless otherwise directed by a medical professional.

In simple terms, pregnenolone sits earlier in the hormone chain than progesterone. That is one key difference. Progesterone is one end product, while pregnenolone helps your body make several different hormones, including sex hormones and other steroid hormones. So they are related, but they are not the same thing.

Pregnenolone also acts as one of the neuroactive steroids. It may influence the central nervous system and how the brain responds to chemicals linked to brain health and cognitive function. Even so, research on brain benefits remains limited, and clear clinical proof is still missing. Additionally, because pregnenolone is a precursor for hormones like estrogen and progesterone, it is sometimes discussed in the context of menopause and reproductive health. However, current scientific evidence does not strongly support its effectiveness for these purposes, and more studies are needed to clarify its role during menopause or for reproductive health.

Will Your or Your Child's Scoliosis Get Worse

How Pregnenolone May Impact Scoliosis Progression

Why would pregnenolone matter in Scoliosis? The study discussed in this article suggests hormone levels may be linked with scoliosis progression. That idea is especially important in adolescent health, where growth can change curve behavior quickly. Pregnenolone supplements are believed to offer several main health benefits, including potential support for memory, mood regulation, and stress reduction, as well as promoting overall hormone balance. These benefits may indirectly influence factors relevant to scoliosis progression, particularly in adolescents undergoing rapid physical development.

Still, you should be careful. Pregnenolone is sold as a dietary supplement, but it is not approved to treat scoliosis. Also, this area does not yet have enough strong clinical trials to tell you who should take it, who should avoid it, or what dose is best, and always keep it out of the reach of children.

  • Higher doses may raise the risk of side effects such as acne, hair growth, irritability, and sexual problems.
  • Children may face a greater risk of hormone-related side effects.
  • Anyone with hormone-sensitive health conditions should talk with a health care provider first.

At its core, the study asked a practical question: are pregnenolone levels linked with scoliosis progression, and can that help predict patient outcomes? That is a useful question because families want early warning signs when a curve may worsen.

The paper also explored this issue inside a real-world care model tied to ScoliSMART rather than classic clinical trials. So, the main goal was not to prove broad health benefits of pregnenolone supplements. It was to see whether measured hormone patterns might matter in scoliosis care.

The study’s main focus was narrow and clinical. It looked at whether pregnenolone levels were associated with scoliosis progression. In other words, the researchers were asking if this hormone marker could help identify which patients might be at greater risk of curve worsening.

That makes the paper different from studies on menopause, reproductive health, or general wellness. It was not trying to show that pregnenolone helps the menstrual cycle, boosts energy levels, or improves broad hormone balance. This peer reviewed research stayed focused on scoliosis.

That focus matters. Many supplement claims drift far beyond the actual evidence. Here, the value of pregnenolone was mainly as a possible biomarker tied to hormone levels and progression risk, not as a proven treatment on its own. That is an important line to keep clear.

For families facing Scoliosis, timing matters. If a curve is likely to worsen, earlier action may improve patient outcomes. That is why evidence based medicine looks for measurable signals, not just guesswork. A hormone marker could become one more tool in that process.

This does not mean pregnenolone supplements are broadly beneficial. It means peer reviewed research is starting to ask whether some patients might have hormone patterns linked with progression. That is a very different claim from saying the supplement helps everyone.

  • The patients who might benefit most are those at higher risk of progression, especially during growth.
  • Even then, stronger clinical trials are still needed before routine use can be recommended.

Delay or eliminate Scoliosis surgery

Study Design and Methods

This paper used a cohort study design rather than randomized clinical trials. That means the researchers looked at a defined patient group and examined patterns in outcomes and measured factors, including pregnenolone. In the event of side effects, it is important to seek medical help. It was not a drug administration study with a standard fixed dose of pregnenolone supplements for all patients.

That distinction matters. A cohort study can show associations, but it is weaker than a trial for proving cause and effect. It also means the paper does not settle questions about the best product form, ideal dose, or supplement industry claims.

The cohort studied consisted of patients with scoliosis seen in a real-world care setting connected to the ScoliSMART approach. The paper centered on progression risk and related hormone findings. Based on the article focus, the cohort was relevant to adolescent health, since progression concerns are highest during growth.

The inclusion criteria were built around having scoliosis and being part of the observed treatment pathway. This was not one of the classic clinical trials that compares matched groups under tightly controlled conditions. Instead, it was a clinical cohort meant to explore patterns.

Study FeatureWhat It Means
Study typeCohort study in a real-world scoliosis care setting
Main populationPatients with scoliosis, with adolescent health being especially relevant
Main questionWhether pregnenolone levels relate to scoliosis progression
Inclusion focusScoliosis cases with available clinical data tied to the care program
Trial typeNot a randomized clinical trial

Interventions Tested, Including the ScoliSMART Approach

The paper looked at pregnenolone within a broader ScoliSMART care model, not as a stand-alone pill study. That is important. The intervention was not simply “take pregnenolone and watch the curve.” It was part of a wider strategy aimed at scoliosis progression.

In practical terms, families may recognize this as a multimodal approach linked with ScoliSMART. Depending on the program, that can sit alongside options people search for, such as a scoliosis brace, Scoliosis exercises, Scoliosis Boot Camp, or the ScoliSMART Activity Suit. The study context was this broader program, not mental health support.

The Supplements For Scoliosis eBook

Discover hope, science, and real solutions—explore The Scoliosis Doctor series on Amazon and start transforming your scoliosis journey today! Download the Kindle app on your mobile device for free! Get it for iPhone. Get it for Android.

Results of Pregnenolone and Scoliosis Progression

The main finding was that pregnenolone levels appeared to be associated with scoliosis progression risk. In simple terms, the hormone signal may help identify patients whose curves are more likely to worsen. That is interesting, especially for early planning.

Still, these results do not carry the same weight as randomized clinical trials. They also do not cancel known side effects or possible risks tied to pregnenolone use. And they do not mean pregnenolone is the same as progesterone or that one can replace the other in care.

Within peer reviewed research, the study’s key finding is best read as an association. The authors linked certain hormone levels, including pregnenolone, with scoliosis progression patterns. That may help with risk stratification, which means sorting patients by likely curve behavior.

This is useful, but you should keep the scope tight. The paper does not show that pregnenolone supplements provide broad health benefits. It does not prove better memory, more energy, or improved mood. Those claims remain uncertain in human studies and other research areas too, and it’s important to store pregnenolone supplements in a cool, dry location.

The strongest clinical meaning is this: patients who may be at higher risk of progression could one day benefit from more targeted monitoring or care choices. That could shape decisions around Scoliosis treatment, but the evidence is not strong enough yet to create a universal rule.

One important data insight is that the study pushes attention toward biology, not just curve size. That is a shift. It suggests scoliosis progression may have measurable internal signals, which could add value to physical exams and imaging.

Another point is what the study did not fully answer. It did not settle whether raising pregnenolone changes outcomes, and it did not define how possible risks should be managed. That matters because human studies on pregnenolone still leave many safety questions open.

  • Known supplement side effects can include acne, increased hair growth, irritability, and sexual problems, especially at higher doses.
  • Drug interactions are not fully understood, so patients should tell a health care provider about hormones, herbal products, and other supplements.

Can Your Child With Scoliosis Replace The Brace and Prevent the Surgery

How Could These Findings Affect Care?

The biggest clinical implication is not “everyone should take pregnenolone.” It is that a health care provider, including your child’s health care provider, may one day use hormone data to refine risk estimates and guide Scoliosis treatment choices. That fits the goals of evidence based medicine.

For now, families should see this as an early signal, not a final answer. In a supplement industry full of bold claims, careful interpretation protects patient outcomes. Hormone data may support decisions, but it should not replace sound clinical judgment.

If you are considering pregnenolone, start with questions, not assumptions. Ask what problem you are trying to solve. Ask whether the goal is to track hormone levels, support a wider plan, or respond to progression risk, as improper use can lead to unwanted side effects. That can improve patient outcomes and lower confusion.

A health care provider should also review your full history. Pregnenolone is a dietary supplement, not a proven scoliosis cure. It may interact with hormone replacement products or other medicines that contain hormones, and should be stored in a location that is not in direct sunlight; research on interactions is incomplete.

  • Do not assume over-the-counter means risk-free.
  • Review possible side effects before using any product.
  • Share all medicines, supplements, and health conditions with your provider.

The ScoliSMART Approach in Managing Scoliosis Progression

The study places pregnenolone inside the ScoliSMART approach, which means it is part of a bigger management strategy. That is the right way to read it. The findings do not say one dietary supplement product fixes scoliosis progression by itself.

Instead, the possible role is supportive. If hormone levels help identify risk, then a health care provider may be able to match care more closely to the patient. For some, it may overlap with Scoliosis exercises or monitoring before Scoliosis surgery is considered.

What about menopause or reproductive health? This study does not answer that. Its value is in scoliosis progression and care planning, not in proving wider hormone benefits outside the scoliosis setting.

Study Limitations and Areas for Further Research

Every useful paper has limits, and this one does too. The biggest study limitations come from the design. Because it was not one of the randomized clinical trials, it cannot firmly prove cause and effect. It can show patterns, not certainty.

That is especially important in the supplement industry, where early findings are often overstated. Future research should test these ideas in stronger peer reviewed research designs. Until then, the paper should be seen as promising, but preliminary.

This study does not prove that low pregnenolone causes scoliosis progression. It also does not prove that taking pregnenolone will stop a curve from worsening. That is the biggest takeaway from the study limitations.

It also does not prove long-term safety. Pregnenolone may be well tolerated at lower amounts in some settings, but higher doses can raise the risk of side effects. Research on drug interactions and long-term use remains incomplete, especially in younger patients.

  • It does not prove pregnenolone is a stand-alone Scoliosis treatment.
  • It does not prove products linked to Supplement Connect or any other supplier work for every patient.

Several gaps remain. First, future research needs stronger clinical trials that compare groups more carefully. Second, studies should report exact dosing plans, length of use, and which patients respond best. Right now, the recommended dosage for pregnenolone supplements is not settled by this paper.

Another gap is safety. Adolescent health deserves special caution because children may have a greater risk of hormone-related effects. Better studies should track side effects, drug interactions, and long-term outcomes.

Finally, peer reviewed research should separate biomarker value from treatment value. In other words, does pregnenolone only help predict risk, or can changing it improve outcomes? That question matters both for science and for judging claims made in the supplement industry.

Scoli Fact-21

Click on the Scoli-Fact to see the rest of the Scoliosis Facts!

Disclosure, Conflicts of Interest, and Source Information

Whenever a study touches a branded program, conflict of interest matters. That does not automatically make the findings wrong, but it does mean readers should pay close attention to peer reviewed research standards and author disclosures.

That same caution applies to product labels and supplement claims in the wider supplement industry. As with other dietary supplements, patients should review product label details, adverse event reporting options, and regulatory limits. In the U.S. that means the FDA; in Canada, Health Canada.

This study was published in a peer reviewed journal, which is important. Peer review helps screen methods and reporting. Still, peer reviewed research standards do not erase the need to inspect author ties and commercial links carefully.

Because the paper discusses the ScoliSMART approach, readers should review the conflict of interest section in the article itself. Based on the article context, any author relationship to the branded program, clinics, or related business entities should be considered when judging the results. That is standard practice, not a personal attack.

For patients, the practical lesson is simple. Bring the paper to your health care provider and discuss it openly. That helps separate useful science from sales messaging, which is especially important in the supplement industry and branded care programs.

For direct review, use the publisher’s page for the article discussed here. Full study citation with link for reference: Journal of Clinical Medicine. 2024;13(3):788. Available at:

If you want to evaluate the paper well, read three parts closely: the abstract, the methods, and the disclosure section. That will help you understand the study citation in context, not just the headline claim.

You may also want to compare the paper with information from your provider and with general supplement safety guidance. That is wise when a study connects with a branded system such as ScoliSMART or a business name such as Supplement Connect.

Conclusion

In summary, the latest study sheds light on the intriguing relationship between pregnenolone levels and scoliosis progression. By focusing on a well-defined cohort and utilizing interventions like the ScoliSMART approach, researchers have provided valuable insights into how hormonal balances may influence spinal health. While the findings are promising, they also come with limitations that highlight the need for further research to fully understand this complex interplay. It’s essential to approach these results with caution, as the study does not prove direct causation between pregnenolone and scoliosis outcomes. For comprehensive insights and to stay updated on future developments, we encourage you to explore the full study here and consider consulting with one of the ScoliSMART doctors who can offer personalized guidance in managing scoliosis progression.

Frequently Asked Questions

Who Might Benefit Most from Therapies Addressing Pregnenolone for Scoliosis Progression?

The most likely group is patients at higher risk of scoliosis progression, especially during adolescent health growth periods. Even then, the use of any dietary supplement related to pregnenolone care should be individualized. Because hormone levels, other health conditions, and safety concerns vary, a provider should guide any decision about supplements or related therapies.